Addition of cetuximab to first-line chemotherapy in patients with advanced non-small-cell lung cancer: a cost-utility analysis

Elsevier, Annals of Oncology, 3(22), p. 567-574, 2011

Journal article published in 2010 by M. Joerger, M. Früh, K. Matter-Walstra

, U. Kühnel, B. Pestalozzi, T. Szucs, M. Schwenkglenks

This paper is made freely available by the publisher.

Full text: Download

Preprint: archiving allowed

Upload

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by